Variant · Snv
NRAS G12D
CI-VAR-00001607Explore in graph →NP_002515.1:p.Gly12AspNM_002524.4:c.35G>AClinVar 39648 CIViC 878 rs121913237
Curated evidence
Evidence by cancer (7 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
- Source
- CIViC — Clinical Interpretation of Variants in Cancer
- Dataset
- CIViC evidence items
- Version
- civic-2026-09-08
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- expert curation
- License
- CC0 1.0
- PMID
- 25666295
- Run
- ING-CIVIC-20260908-000001
| Molecular profile | Therapy | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| Malignant Colorectal Neoplasm7 | ||||||||
| NRAS G12D | Cetuximab | Predictive | B | Supports Resistance | — | accepted | EID3693In a retrospective study of 148 treatment naive metastatic colorectal cancer patients, patients with RAS mutations (n=10), including KRAS A146T, KRAS G13D, NRAS G12D and NRAS Q179*, treated with FOLFO… (full text at CIViC) PMID 25666295 · Kaczirek et al., 2015 · Open in CIViC | civic |
| NRAS G12D | Cetuximab | Predictive | D | Supports Resistance | — | submitted | EID3691In an in vitro study, an OXCO-2 cell line expressing NRAS G12D mutation demonstrated acquired resistance after low level cetuximab exposure compared to OXCO-2 parental cells expressing NRAS wild-type.… (full text at CIViC) PMID 24553387 · Misale et al., 2014 · Open in CIViC | civic |
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-24
- Retrieved
- Sep 29, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260929-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 39648 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts | 2 | Epidermal nevus; Juvenile myelomonocytic leukemia; Noonan syndrome 6; Noonan syndrome and Noonan-related syndrome; RASopathy; Autoimmune lymphoproliferative syndrome type 4; NRAS-related disorder; Cardiovascular phenotype; Colorectal cancer; Large congenital melanocytic nevus; Germinoma; Neoplasm | germline/somatic |